Evid Invest
Holders — by stockHoldings — by fund

Elmind Capital, LP

Everything this manager disclosed owning in US-listed stocks — its complete Form 13F portfolio · as of 2026-09-30 · filed with the SEC up to 45 days after quarter end · CIK 0002052213

$403.8M

disclosed book value

30

positions

8.9%

largest position share

Positions, as of 2026-09-30

top 30 of 30 · 13F covers long US-listed positions only — cash, bonds, private and foreign stakes are not disclosed · PUT/CALL tags = options positions (share-equivalents), not shares held

#IssuerSharesValue% of book
1CLDXCELLDEX THERAPEUTICS INC NEW1.1M$36.0M8.9%
2LEGNLEGEND BIOTECH CORP1.6M$31.2M7.7%
3SNDXSYNDAX PHARMACEUTICALS INC1.6M$30.2M7.5%
4COGTCOGENT BIOSCIENCES INC866,742$27.8M6.9%
5RLAYRELAY THERAPEUTICS INC1.5M$26.4M6.5%
6AMLXAMYLYX PHARMACEUTICALS INC894,760$26.0M6.4%
7VRDNVIRIDIAN THERAPEUTICS INC1.2M$25.2M6.2%
8PCVXVAXCYTE INC372,340$21.2M5.2%
9URGNUROGEN PHARMA LTD491,100$20.0M4.9%
10TVTXTRAVERE THERAPEUTICS INC322,600$19.0M4.7%
11CGEMCULLINAN THERAPEUTICS INC962,792$14.8M3.7%
12PHVSPHARVARIS N V455,750$14.5M3.6%
13VERAVERA THERAPEUTICS INC436,518$14.1M3.5%
14CTMXCYTOMX THERAPEUTICS INC.4.5M$12.4M3.1%
15BEAMBEAM THERAPEUTICS INC476,338$11.6M2.9%
16NRIXNURIX THERAPEUTICS INC460,000$10.9M2.7%
17SMMTSUMMIT THERAPEUTICS INC493,820$8.4M2.1%
18UTHRUNITED THERAPEUTICS CORP DEL15,000$8.1M2%
19IMCRIMMUNOCORE HLDGS PLC256,143$7.8M1.9%
20KRYSKRYSTAL BIOTECH INC22,000$7.3M1.8%
21ALMSALUMIS INC749,560$5.5M1.4%
22BCRXBIOCRYST PHARMACEUTICALS INC520,000$4.3M1.1%
23STROSUTRO BIOPHARMA INC228,265$3.7M0.9%
24MBXMBX BIOSCIENCES INC61,000$3.6M0.9%
25DBVTDBV TECHNOLOGIES S A265,000$3.1M0.8%
26SUPNSUPERNUS PHARMACEUTICALS70,000$3.0M0.7%
27BMRNBIOMARIN PHARMACEUTICAL INC47,000$2.8M0.7%
28SEPNSEPTERNA INC49,444$1.9M0.5%
29ALECALECTOR INC915,902$1.7M0.4%
30DSGNDESIGN THERAPEUTICS INC107,900$1.4M0.3%

Source: SEC Form 13F-HR, reporting period 2026-09-30. Values are the manager's filed June-30-style quarter-end marks, not live prices. Research, not investment advice.

EvidInvest is an independent research and information tool. Figures are calculated from public SEC filings and third-party market data and are provided for informational and educational purposes only. EvidInvest does not provide investment advice, brokerage, or financial services, and is not affiliated with any company it covers. Verify all figures against primary sources before making any decision.